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Nishimura et al., page 686; Collin et al., page 783
Although the number of genes in which retinitis pigmen-
tosa (RP)-causing mutations have been identiﬁed is
growing, the etiology of a large proportion of cases remains
unknown. Homozygosity mapping can be a useful tool in
identifying loci for autosomal-recessive diseases in consan-
guineous families and isolated populations. In this issue,
Nishimura and colleagues and Collin and colleagues use
homozygosity mapping to search for the genes disrupted
in their RP families. The region identiﬁed is quite large,
so Nishimura et al. narrow the list of candidate genes by
comparing gene expression in wild-type mice to that of
mice lacking photoreceptors. The idea is that genes that
are speciﬁcally expressed in the photoreceptors are more
likely to be critical in the development of the retina;
therefore, disruption of such genes might cause RP. This
approach allows both groups to focus on and then identify
mutations in C2ORF71 that segregate with RP in their
families. The Nishimura team then goes on to characterize
the gene product of C2ORF71 in cellular assays, in localiza-
tion studies, and through analysis of a zebraﬁsh model.16p13.11 Deletions in Epilepsy Syndromes
Heinzen et al., page 707
Copy-number variants (CNVs), caused by genomic rear-
rangements, have recently been associated with a myriad
of common disorders. Among these are several neurolog-
ical conditions, including schizophrenia, mental retarda-
tion, and idiopathic generalized epilepsy. Interestingly,
several CNV risk loci are shared among these conditions,
pointing to a common origin. Despite these associations,
there is a general lack of understanding concerning how
CNVs actually lead to most associated disorders. In this
issue, Heinzen and colleagues investigate the propensity
of CNVs in a spectrum of epilepsy disorders. Because
CNVs on 15q13.3, 15q11.2, and 16p13.11 have previously
been associated with idiopathic generalized epilepsy, these
authors evaluate the same risk loci in a cohort of nearly
4000 patients with diverse types of epilepsy. Although
CNVs in neither of the 15q regions are found to play
a signiﬁcant role in epilepsy cases other than idiopathic
generalized epilepsy, a signiﬁcant number of cases are
found to carry deletions greater than 100 kb at 16p13.11.1Science Editor, AJHG; 2Deputy Editor, AJHG
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The AmeAdditionally, deletions greater than 2 Mb are found at
this same locus in some epilepsy patients, whereas no
such deletions are detected in controls. Functional anal-
yses indicate that haploinsufﬁciency may play a role in
the pathogenesis of these CNVs.Genetics of ER Stress Response
Dombroski et al., page 719
The endoplasmic reticulum (ER) is a site of protein and
lipid processing in cells. When cell conditions are not
ideal, ER functions can be affected and unfolded proteins
can accumulate and aggregate in the ER. This altered state,
termed ER stress, is harmful and has been implicated in
human disease. Cells work to reverse the negative effects
through the unfolded protein response (UPR). The UPR
involves inhibition of general protein synthesis, degrading
of misfolded proteins, and increased ER capabilities. If
the pathways initiated via the UPR are not effective in
reducing the ER stress, cells will undergo apoptosis. In
this issue, Dombroski and colleagues perform expression
analyses to identify which genes are activated after phar-
macological induction of ER stress and to see how much
individual variation is present in expression levels. The
authors then examine these genes in twin pairs to establish
which elements of the UPR are most likely to be under
genetic control. It is hoped that a comprehensive analysis
of UPR genes not only will further elucidate the cellular
response to ER stress but will also contribute to under-
standing the pathways that are dysfunctional in certain
diseases.Causal Variants in GWAS
Wang et al., page 730
Unlike the traditionally held hypothesis that a marker
signiﬁcantly associated with a disease either is causal itself
or is in high linkage disequilibrium (LD) with a causal
marker, it is possible that a common disease-associated
SNP does not proxy for a single causal variant but in fact
tags several rare causal alleles. If multiple variants that
contribute to disease risk each happen to arise on the
same haplotype background containing a common SNP,
then the common SNP will appear to be signiﬁcantly asso-
ciated with the disease. The situation can be even more
complicated, because some of the rare variants may be inGenetics. All rights reserved.
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LD with the ‘‘risk’’ allele of a common SNP whereas other
rare causal alleles are on the same haplotype as the ‘‘protec-
tive’’ common-SNP allele. Here, Wang and colleagues
examine this situation further to see how the phenom-
enon can affect the results of association studies. The
authors demonstrate that the presence of multiple rare
causal variants can produce underestimates of effect size
and also lead to lower measures of heritability. Impor-
tantly, they also examine how current ﬁne-mapping proce-
dures are ill-equipped to identify multiple rare variants and
propose that careful selection of cases for resequencing will
be crucial for effective identiﬁcation of these causal alleles.
Ideal cases for this procedure are those who contain long-
range haplotypes at the associated locus. These haplo-
toypes are likely to be enriched with newly acquired rare
alleles, and sequencing of such individuals will hopefully
improve the chance that the rare causal alleles will be iden-
tiﬁed in ﬁne-mapping efforts.Chromosomal Array: An Economical First-Tier Test
Miller et al., page 749; Regier et al., page 765
Array-based methods designed to detect the presence of
unbalanced copy-number changes within a genome are
becoming more routine in the clinical setting. These
molecular-genetics techniques, commonly referred to as
array genomic hybridization (AGH) or chromosomal658 The American Journal of Human Genetics 86, 657–658, May 14,microarray (CMA), are commonly used to identify chro-
mosomal changes in patients with intellectual disability
(ID). AGH/CMA is much more sensitive than traditional
G-banded karyotyping; detecting chromosomal imbal-
ances around 100 times smaller than those identiﬁed by
standard karyotyping. However, to date, there is relatively
little that has been published concerning the efﬁciency or
the cost-effectiveness of such methods. In this issue, two
groups tackle these separate questions individually. Reiger
and colleagues conduct an in-depth analysis of the
economics of AGH. These authors compare simulations
of two scenarios of treatment for patients suspected of
having a trisomy; in each scenario, either AGH is used as
a ﬁrst-tier test or karyotyping is the front-line method.
Realistic follow-up procedures are calculated into each
scenario. Although AGH costs more than traditional cyto-
geneticmethods, these authors conclude that in the case of
ID detection, AGH is cost effective. In a related, but
distinct, study, the International Standard Cytogenomic
Array (ISCA) Consortium, reported here by Miller and
colleagues, analyze published studies and compare the efﬁ-
cacy of CMA and G-banded karyotyping. They recom-
mend that CMA be used as a ﬁrst-tier approach in cases
of ID, autism spectrum disorders, and multiple congenital
anomalies. Recommendations are also made regarding the
use of karyotyping. Together, these two studies highlight
the utility and cost of AGH/CMA and provide suggestions
regarding the implementation of such methods.2010
